Status:
UNKNOWN
Study of Long-Term Use of Proton-Pump-Inhibitors in General Practice
Lead Sponsor:
Glostrup University Hospital, Copenhagen
Conditions:
Dyspepsia
Gastroesophageal Refluxdisease
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The primary purpose of the study is to determine the effect of esomeprazole compared to placebo in patients from general practice who have previously been treated with proton-pump-inhibitors (PPI) and...
Detailed Description
The majority of patients with dyspepsia are treated in primary care with acid-suppressive therapy for shorter or longer periods of time on the assumption that the patients´ symptoms are related to the...
Eligibility Criteria
Inclusion
- Treatment with PPI in at least 4 months out of the preceding 12.
- Use of PPI in the preceding 10 out of 30 days before inclusion
- Age above 18 years
Exclusion
- Erosive Esophagitis
- PPI-treatment as prophylaxis against gastrointestinal bleeding
- PPI-treatment as prophylaxis against ulcers
- PPI-treatment as prophylaxis because of NSAID-treatment
- Pregnant or lactating women
- Previous upper GI surgery
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
End Date :
February 1 2008
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00363701
Start Date
August 1 2006
End Date
February 1 2008
Last Update
August 15 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of gastroenterology, Glostrup University Hospital
Glostrup Municipality, Denmark, 2600